by | Jan 13, 2026 | Brestoff Parker, Jonathan, Diamond, Michael, Jia, Wentong
— Published date: 1/14/2026
Value Proposition: Novel target for therapeutic treatment of obesity and related metabolic diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a therapeutic targeting MXRA8 to treat obesity and associated metabolic disea…
by | Jan 12, 2026 | Ly, Amy, Maher, Christopher, Maher, Nicole, Nickless, Andrew, Webster, Jace, Zhang, Jin
— Published date: 1/13/2026
Value Proposition: Predictive biomarkers that can identify patients that would respond well to HER2 targeted breast cancer treatment that are not currently being treated this way.
Technology Description
Researchers at Washington University in St. Louis have establis…
by | Jun 3, 2025 | Feldman, Mario, Jana, Biswanath, Pardue, Evan, Sartorio, Mariana
— Published Date: 6/3/2025
Value Proposition: System that employs gut microbe strains engineered with therapeutic enzymes to treat chronic gut conditions.
Technology Description
Researchers at Washington University in St. Louis have developed a hypervesiculating Bacteroides theatiotaomicron (Bt) …
by | May 13, 2025 | Haller, Gabriel, Li, Chengcheng, Weihl, Conrad
— Published Date: 5/14/2025
Value Proposition: Method that uses gene-therapy to detect limb-girdle muscular dystrophy (LGMD) type 4R/2E.
Technology Description
Researchers at Washington University in St. Louis have developed a method of predicting limb-girdle muscular dystrophy (LGMD) type 4R/2…
by | Jan 3, 2025 | Blake, Kevin, Dantas, Gautam, DeAngelo, Caitlin, Wencewicz, Timothy, Williford, Emily
— Published Date: 1/4/2025
Value Proposition: New composition of matter that combines tetracycline class compounds with destructase inhibitors to overcome resistance to tetracycline antibiotics.
Technology Description
Researchers at Washington University in St. Louis have developed an enzymatic…